🎁 Black Friday: up to 50% off of annual plans
GenMont Biotech Incorporation (TPE:3164)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
15.45
-1.05 (-6.36%)
Nov 20, 2026, 1:30 PM CST

TPE:3164 Income Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
396.64401.23385.37318.02368.55427.93
Revenue Growth
1.32%4.11%21.18%-13.71%-13.88%31.59%
Cost of Revenue
162.31149.6147.19106.82111.83128.6
Gross Profit
234.32251.63238.18211.19256.72299.33
Selling, General & Admin
145.48147.82152.79156.6137.12145.47
Research & Development
44.3745.3445.2746.8659.4125.52
Operating Expenses
195.8193.88197.55204.2194.75174.29
Operating Income
38.5357.7540.636.9961.97125.04
Interest Expense
-3.92-3.92-3.72-0.97-0.76-0.77
Interest & Investment Income
6.967.3911.69.464.82.35
Currency Exchange Gain (Loss)
-3-317.05-6.9810.45-1.35
Other Non Operating Income (Expenses)
33.791.440.40.34-1.981.06
EBT Excluding Unusual Items
72.3759.6765.978.8374.48126.34
Gain (Loss) on Sale of Investments
4.024.02-1.2319.05-8.169.35
Gain (Loss) on Sale of Assets
-0-0-0.020.28-0.063.74
Pretax Income
76.3863.6864.7228.1666.26139.42
Income Tax Expense
24.615.716.975.7318.829.82
Earnings From Continuing Operations
51.7847.9847.7522.4347.46109.6
Net Income to Company
51.7847.9847.7522.4347.46109.6
Minority Interest in Earnings
10.239.229.510.569.523.53
Net Income
62.0157.257.2532.9956.98113.13
Net Income to Common
62.0157.257.2532.9956.98113.13
Net Income Growth
79.79%-0.09%73.53%-42.10%-49.64%85.82%
Shares Outstanding (Basic)
878687868686
Shares Outstanding (Diluted)
878787878787
Shares Change
-0.17%-0.23%0.18%-0.10%-0.09%-1.50%
EPS (Basic)
0.710.660.660.380.661.31
EPS (Diluted)
0.710.660.660.380.661.30
EPS Growth
81.62%0%73.68%-42.40%-49.25%88.41%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
118.1370.1979.891.2965.79-5.28
Free Cash Flow Per Share
1.350.810.920.010.76-0.06
Dividend Per Share
0.8000.8000.8000.5000.7001.100
Dividend Growth
0%0%60.00%-28.57%-36.36%57.14%
Gross Margin
59.08%62.72%61.80%66.41%69.66%69.95%
Operating Margin
9.71%14.39%10.54%2.20%16.81%29.22%
Profit Margin
15.63%14.26%14.86%10.37%15.46%26.44%
Free Cash Flow Margin
29.78%17.49%20.73%0.41%17.85%-1.23%
EBITDA
103.5120.57108.1868.77109.92143.05
EBITDA Margin
26.09%30.05%28.07%21.63%29.82%33.43%
D&A For EBITDA
64.9762.8167.5561.7947.9518.02
EBIT
38.5357.7540.636.9961.97125.04
EBIT Margin
9.71%14.39%10.54%2.20%16.81%29.22%
Effective Tax Rate
32.21%24.65%26.22%20.35%28.37%21.39%